Cargando…
Na(v)1.1 Modulation by a Novel Triazole Compound Attenuates Epileptic Seizures in Rodents
[Image: see text] Here, we report the discovery of a novel anticonvulsant drug with a molecular organization based on the unique scaffold of rufinamide, an anti-epileptic compound used in a clinical setting to treat severe epilepsy disorders such as Lennox-Gastaut syndrome. Although accumulating evi...
Autores principales: | Gilchrist, John, Dutton, Stacey, Diaz-Bustamante, Marcelo, McPherson, Annie, Olivares, Nicolas, Kalia, Jeet, Escayg, Andrew, Bosmans, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027953/ https://www.ncbi.nlm.nih.gov/pubmed/24635129 http://dx.doi.org/10.1021/cb500108p |
Ejemplares similares
-
Huperzine A Provides Robust and Sustained Protection against Induced Seizures in Scn1a Mutant Mice
por: Wong, Jennifer C., et al.
Publicado: (2016) -
Epileptic seizures
por: Anwar, Haleema, et al.
Publicado: (2020) -
Fahr's disease with an atypical onset of epileptic seizure
por: Sudan, Sourav, et al.
Publicado: (2022) -
Association of RASgrf1 methylation with epileptic seizures
por: Chen, Xiaoni, et al.
Publicado: (2017) -
Beclin1 Deficiency Suppresses Epileptic Seizures
por: Yang, Min, et al.
Publicado: (2022)